BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 35814440)

  • 1. A Nomogram Model to Predict Early Recurrence of Patients With Intrahepatic Cholangiocarcinoma for Adjuvant Chemotherapy Guidance: A Multi-Institutional Analysis.
    Li Q; Zhang J; Chen C; Song T; Qiu Y; Mao X; Wu H; He Y; Cheng Z; Zhai W; Li J; Zhang D; Geng Z; Tang Z
    Front Oncol; 2022; 12():896764. PubMed ID: 35814440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma.
    Xu Y; Li Z; Yang Y; Li L; Zhou Y; Ouyang J; Huang Z; Wang S; Xie L; Ye F; Zhou J; Ying J; Zhao H; Zhao X
    Insights Imaging; 2023 Oct; 14(1):173. PubMed ID: 37840098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
    Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
    Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a novel prognostic model for intrahepatic cholangiocarcinoma based on a combined scoring system of systemic immune-inflammation index and albumin-bilirubin: a multicenter study.
    Zhang H; Li Q; Huang G; Yang Z; Chen K; Meng B; Yu H
    Front Oncol; 2023; 13():1239375. PubMed ID: 37841429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perineural invasion confers poorer clinical outcomes in patients with T1/T2 intrahepatic cholangiocarcinoma: a single center, retrospective cohort study.
    Zou M; Sheng J; Ruan M; Zhou W; Ye F; Yang G; Qian Y; Wang J; Wang R; Liu S; Liu H
    J Gastrointest Oncol; 2023 Dec; 14(6):2500-2510. PubMed ID: 38196519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis.
    Feng X; Chen W; Tao R; Yuan J; Ruan M; Du J; Guo X; Liu F; Liu H
    J Gastrointest Oncol; 2023 Oct; 14(5):2229-2242. PubMed ID: 37969826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma.
    Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
    Abdom Radiol (NY); 2024 Feb; 49(2):425-436. PubMed ID: 37889266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of recurrent intrahepatic cholangiocarcinoma: predictors, adjuvant chemotherapy, and surgical therapy for recurrence: A multi-institutional study by the Kyushu Study Group of Liver Surgery.
    Yamashita YI; Shirabe K; Beppu T; Eguchi S; Nanashima A; Ohta M; Ueno S; Kondo K; Kitahara K; Shiraishi M; Takami Y; Noritomi T; Okamoto K; Ogura Y; Baba H; Fujioka H
    Ann Gastroenterol Surg; 2017 Jun; 1(2):136-142. PubMed ID: 29863136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional recurrence analysis of intrahepatic cholangiocarcinoma: Changes in recurrence rate and survival after recurrence resection by disease-free interval.
    Maki H; Kawaguchi Y; Nagata R; Mihara Y; Ichida A; Ishizawa T; Akamatsu N; Kaneko J; Arita J; Hasegawa K
    Hepatol Res; 2023 Dec; 53(12):1224-1234. PubMed ID: 37559185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma.
    Cai C; Tao L; Li D; Wang L; Xiao E; Luo G; Yan Z; Wang Y; Li D
    Scand J Gastroenterol; 2024 Mar; 59(3):333-343. PubMed ID: 38018772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and validation of a nomogram model for preoperative prediction of the risk of cholangiocarcinoma with perineural invasion.
    Wang M; Sun Z; Wang Q; Guo J; Li X; Chen J; Zhang B; Dai D; Feng Y
    Am J Cancer Res; 2023; 13(11):5082-5093. PubMed ID: 38058832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of sarcopenia on the short-term and long-term outcomes of intrahepatic cholangiocarcinoma undergoing hepatectomy: A multi-center study.
    Li R; Chen B; Chen Z; Su Q; He Q; Yang J; Xu P; Hu J; Jin Y; Bo Z
    Eur J Surg Oncol; 2024 Apr; 50(4):108246. PubMed ID: 38484491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence and multi-omics driven models would be the future of intrahepatic cholangiocarcinoma prediction research.
    Ding Z; Zeng Y
    Hepatobiliary Surg Nutr; 2024 Jun; 13(3):560-561. PubMed ID: 38911202
    [No Abstract]   [Full Text] [Related]  

  • 14. Gallbladder cancer: current and future treatment options.
    Zhou Y; Yuan K; Yang Y; Ji Z; Zhou D; Ouyang J; Wang Z; Wang F; Liu C; Li Q; Zhang Q; Li Q; Shan X; Zhou J
    Front Pharmacol; 2023; 14():1183619. PubMed ID: 37251319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Textbook outcome in gallbladder carcinoma after curative-intent resection: a 10-year retrospective single-center study.
    Li Q; Liu H; Gao Q; Xue F; Fu J; Li M; Yuan J; Chen C; Zhang D; Geng Z
    Chin Med J (Engl); 2023 Jul; 136(14):1680-1689. PubMed ID: 37166217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized intrahepatic cholangiocarcinoma prognosis prediction using radiomics: Application and development trend.
    Chen P; Yang Z; Zhang H; Huang G; Li Q; Ning P; Yu H
    Front Oncol; 2023; 13():1133867. PubMed ID: 37035147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Fibrinogen Albumin Ratio is an Effective Biomarker for Prognostic Evaluation of Gallbladder Carcinoma After Radical Resection: A 10-Year Retrospective Study at a Single Center.
    Li Q; Zhang J; Gao Q; Fu J; Li M; Liu H; Chen C; Zhang D; Geng Z
    J Inflamm Res; 2023; 16():677-689. PubMed ID: 36844254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.
    Alaimo L; Lima HA; Moazzam Z; Endo Y; Yang J; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Kitago M; Pawlik TM
    Ann Surg Oncol; 2023 Sep; 30(9):5406-5415. PubMed ID: 37210452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for cholangiocarcinoma after surgery and prognosis factors for cholangiocarcinoma: A single-center retrospective cohort study.
    Sun Z; Han X; You W; Tang J; Xu J; Ye B; Li T; Zhang Y; Chen K; Ding Y; Wang W
    Front Oncol; 2023; 13():1116338. PubMed ID: 37007129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning radiomics to predict the early recurrence of intrahepatic cholangiocarcinoma after curative resection: A multicentre cohort study.
    Bo Z; Chen B; Yang Y; Yao F; Mao Y; Yao J; Yang J; He Q; Zhao Z; Shi X; Chen J; Yu Z; Yang Y; Wang Y; Chen G
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2501-2513. PubMed ID: 36922449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.